NVST Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeP/E ratio94.04Forward 20.33
EPS (TTM)$0.283146.0% YoY
Profit margin1.7%HEALTHCARE
Market cap$4.29BMid cap
Wall Street coverage
$28.69median target· current $19.06 (+50.5%)14 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Valuation
- Forward P/E
- 20.33
- PEG ratio
- —
- P/B
- 1.38
- P/S (TTM)
- 1.58
- EV/EBITDA
- 12.83
Profitability & growth
- ROE (TTM)
- 1.6%
- Operating margin
- 10.7%
- Revenue growth YoY
- 15.0%
- Dividend yield
- —
- Beta
- 0.98
Last earnings
Feb 5, 2026 · Estimate $0.32 · Reported $0.38
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Envista Holdings Corp
Company profileEnvista Holdings Corporation, develops, manufactures and markets dental products in the United States and internationally. The company is headquartered in Brea, California.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- BUILDING E, BREA, CA
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Market cap$4.29B
Shares outstanding$163.0M
52W high$30.42
52W low$16.32
Educational content · Not investment advice or recommendations
We're educators, not advisors. Your decisions are your own. Disclaimer
B
Agent
The AI built for clarity
I'm your AI thinking companion for the markets — I can help you explore and learn, but I'm not a financial advisor. Everything here is educational. Disclaimer
B
Agent